Genzyme H-1B Salaries 2026
19 certified H-1B Labor Condition Applications for full-time roles at Genzyme, decided Jul 1, 2025 – Jun 30, 2026. Median offered salary $147,000.
$147,000Median salary
$123,75025th percentile
$160,60875th percentile
19Filings
Genzyme H-1B salaries by job title
| Job title | Filings | Median |
|---|---|---|
| Systems Support Manager | 1 | $126,243 |
| Associate Director Dupixent Payer Analytics and Insights Lead | 1 | $147,000 |
| Associate Director Cross Portfolio Analytics Vaccines | 1 | $125,250 |
| Associate Director Forecasting Rare Blood Disorders | 1 | $148,500 |
| Senior Product Manager U S Allergy Marketing | 1 | $122,250 |
| Senior Director US Commercial Insights and Analytics | 1 | $206,250 |
| Senior Scientist | 1 | $100,500 |
| Principal Scientist I Investigative Pathologist | 1 | $150,779 |
| Manager Commercial Leadership Development Program | 1 | $122,250 |
| Chromatography Principal Scientist | 1 | $151,674 |
| Associate Director of Field Sales Analytics & Effectiveness | 1 | $169,541 |
| Safety Governance Expert | 1 | $100,500 |
| Associate Marketing Director Dermatology Patient Marketing | 1 | $140,625 |
| Senior Global Medical Lead | 1 | $225,000 |
| AI Systems & ML Scientist | 1 | $113,464 |
Top cities
| City | Filings | Median |
|---|---|---|
| Cambridge, MA | 14 | $148,631 |
| Morristown, NJ | 2 | $147,396 |
| Framingham, MA | 2 | $106,982 |
| Jersey City, NJ | 1 | $147,000 |
Wage levels
Prevailing-wage level the employer selected (I = entry, IV = fully competent).
Median prevailing wage on these filings: $126,243.
Recent Genzyme H-1B filings
Latest 19 of 19 filings by decision date. Salary is the offered wage rate (annualised); "to" shows the top of a range when given.
| Certified | Job title | Salary |
|---|---|---|
| 2026-06-23 | Safety Governance Expert | $100,500 to $167,500 |
| 2026-06-01 | Associate Director of Field Sales, Analytics & Effectiveness | $169,541 to $247,500 |
| 2026-05-29 | Chromatography Principal Scientist | $151,674 to $176,583 |
| 2026-05-21 | Manager, Commercial Leadership Development Program | $122,250 to $203,750 |
| 2026-05-01 | Principal Scientist I, Investigative Pathologist | $150,779 to $203,750 |
| 2026-04-27 | Senior Scientist | $100,500 to $167,500 |
| 2026-04-27 | Senior Director, US Commercial Insights and Analytics | $206,250 to $343,750 |
| 2026-04-07 | Sr. Product Manager - U.S. Allergy Marketing | $122,250 to $203,750 |
| 2026-03-05 | Associate Director, Forecasting Rare Blood Disorders | $148,500 to $247,500 |
| 2026-02-27 | Associate Director, Cross-Portfolio Analytics – Vaccines | $125,250 to $208,750 |
| 2025-11-14 | Assoc. Director, DUPIXENT Payer Analytics and Insights Lead | $147,000 to $250,000 |
| 2025-11-14 | Systems Support Manager | $126,243 to $167,500 |
| 2025-09-25 | Associate Marketing Director, Dermatology Patient Marketing | $140,625 to $234,375 |
| 2025-08-28 | Senior Global Medical Lead | $225,000 to $350,000 |
| 2025-08-06 | AI Systems & ML Scientist | $113,464 to $141,250 |
| 2025-07-29 | Director, Global Hemophilia Marketing | $240,053 to $287,500 |
| 2025-07-08 | Director, National Accounts, Medical Value and Outcomes | $203,154 to $335,000 |
| 2025-07-03 | Senior Manager, Advanced Analytics | $148,762 to $181,250 |
| 2025-07-01 | Associate Director, Strategy and Ops, Global Immunology | $147,000 to $245,000 |
Employer names as filed: Genzyme Corporation. Name variants that differ only in case, punctuation or legal suffix (LLC, Inc., Corp.) are merged. Separate legal entities are listed separately. These are wages offered on certified LCAs, not actual pay.